Significant Transcriptomic Changes Are Associated with the Inhibitory Effects of 5-aza-2-deoxycytidine During Adipogenic Differentiation of MG-63 Cells

Overview

Journal Saudi J Biol Sci

Specialty Biology

Date 2021 Dec 6

PMID 34867036

Citations 1

Authors

Amir Ali Khan

Muhammad Nasir Khan Khattak

Divyasree Parambath

Ahmed Taher El-Serafi

Affiliations

Soon will be listed here.

Abstract

Our previous study revealed that the treatment of 5-aza-2-deoxycytidine (5-aza) inhibited while treatment of suberoylanilide hydroxamic acid (SAHA) enhanced the adipogenic differentiation of MG-63 cells. In this study, we examined the transcriptomic profiles of the derived adipocyte-like cells from MG-63 cells in the presence of 5-aza (Treatment 1) and SAHA (Treatment 2). Genome wide expression analysis showed high within sample variability for the adipocytes derived with 5-aza versus vehicle. Additionally, the expression profile of 5-aza derived cells was separated from the other sample groups. Differential analysis on the pairwise comparison of 5-aza versus control and SAHA versus 5-aza identified 1290 and 1086 differentially expressed (DE) genes, respectively. Furthermore, some overlap was observed between the up and down-regulated DE genes of 5-aza versus control and SAHA versus control (jaccard score 0.3) as well as between the differentially regulated genes of 5-aza versus control and 5-aza versus SAHA (jaccard score 0.29). A total of 73 transcription factors (TFs) were differentially expressed across all the pair wise comparisons with some overlap between the under and over expressed TFs of 5-aza versus control and 5-aza versus SAHA (jaccard score 0.29). Unsupervised clustering of TFs showed that the samples within the group are consistent in expression and the samples cluster in accordance with the group. Several GO terms related to enhanced adipogenesis such as neutral lipid biosynthetic process, lipid metabolic processes, cellular amide metabolic processes and cellular carbohydrate metabolic processes were enriched in the down regulated genes of 5-aza derived adipocytes versus control, indicating 5-aza inhibit the adipogenic differentiation of MG-63 cells. GSEA analysis on selected gene sets of MAPK and PI3K signaling pathway in MSigDB identified the pathways were up-regulated in 5-aza versus control. This study revealed that inhibition of MG-63 adipogenesis due to 5-aza treatment is associated with large transcriptomics changes and further research is needed to unravel the roles of these genes in the adipogenesis.

Citing Articles

Non-additive effect of the DNA methylation inhibitor, 5-Aza-dC, and glass as a culture surface on osteogenic differentiation.

Alghfeli L, Parambath D, Tag Eldeen L, El-Serafi I, El-Serafi A Heliyon. 2023; 8(12):e12433.

PMID: 36590514 PMC: 9794900. DOI: 10.1016/j.heliyon.2022.e12433.

References

Beale E, Harvey B, Forest C . PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem Biophys. 2007; 48(2-3):89-95. DOI: 10.1007/s12013-007-0025-6. View

Fayyad A, Khan A, Abdallah S, Alomran S, Bajou K, Khattak M . Rosiglitazone Enhances Browning Adipocytes in Association with MAPK and PI3-K Pathways During the Differentiation of Telomerase-Transformed Mesenchymal Stromal Cells into Adipocytes. Int J Mol Sci. 2019; 20(7). PMC: 6480475. DOI: 10.3390/ijms20071618. View

Chawla K, Tripathi S, Thommesen L, Laegreid A, Kuiper M . TFcheckpoint: a curated compendium of specific DNA-binding RNA polymerase II transcription factors. Bioinformatics. 2013; 29(19):2519-20. DOI: 10.1093/bioinformatics/btt432. View

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

Agrawal M, Yeo C, Shabbir A, Chhay V, Silver D, Magkos F . Fat storage-inducing transmembrane protein 2 (FIT2) is less abundant in type 2 diabetes, and regulates triglyceride accumulation and insulin sensitivity in adipocytes. FASEB J. 2018; 33(1):430-440. DOI: 10.1096/fj.201701321RR. View

Li B, Dewey C . RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011; 12:323. PMC: 3163565. DOI: 10.1186/1471-2105-12-323. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Chen J, Gao Y, Huang H, Xu K, Chen X, Jiang Y . The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells. Stem Cells. 2014; 33(3):686-98. DOI: 10.1002/stem.1879. View

Kim H, Bae S . Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011; 3(2):166-79. PMC: 3056563. View

10.

Sumida K, Igarashi Y, Toritsuka N, Matsushita T, Abe-Tomizawa K, Aoki M . Effects of DMSO on gene expression in human and rat hepatocytes. Hum Exp Toxicol. 2011; 30(10):1701-9. DOI: 10.1177/0960327111399325. View

11.

Li Y, Jin D, Xie W, Wen L, Chen W, Xu J . PPAR-γ and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively. Curr Stem Cell Res Ther. 2017; 13(3):185-192. DOI: 10.2174/1574888X12666171012141908. View

12.

Bhatt-Wessel B, Jordan T, Miller J, Peng L . Role of DGAT enzymes in triacylglycerol metabolism. Arch Biochem Biophys. 2018; 655:1-11. DOI: 10.1016/j.abb.2018.08.001. View

13.

Elsharkawi I, Parambath D, Saber-Ayad M, Khan A, El-Serafi A . Exploring the effect of epigenetic modifiers on developing insulin-secreting cells. Hum Cell. 2019; 33(1):1-9. DOI: 10.1007/s13577-019-00292-y. View

14.

Khan A, Jong Huat T, Mutery A, El-Serafi A, Hadj Kacem H, Abdallah S . Significant transcriptomic changes are associated with differentiation of bone marrow-derived mesenchymal stem cells into neural progenitor-like cells in the presence of bFGF and EGF. Cell Biosci. 2020; 10:126. PMC: 7594431. DOI: 10.1186/s13578-020-00487-z. View

15.

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

16.

El-Serafi A, Sandeep D, Abdallah S, Lozansson Y, Hamad M, Khan A . Paradoxical effects of the epigenetic modifiers 5-aza-deoxycytidine and suberoylanilide hydroxamic acid on adipogenesis. Differentiation. 2019; 106:1-8. DOI: 10.1016/j.diff.2019.02.003. View

17.

Jones P, Takai D . The role of DNA methylation in mammalian epigenetics. Science. 2001; 293(5532):1068-70. DOI: 10.1126/science.1063852. View

18.

Thaler R, Spitzer S, Karlic H, Klaushofer K, Varga F . DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells. Epigenetics. 2012; 7(6):635-51. PMC: 3398991. DOI: 10.4161/epi.20163. View

19.

El-Serafi A, Oreffo R, Roach H . Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin A. Differentiation. 2010; 81(1):35-41. DOI: 10.1016/j.diff.2010.09.183. View

20.

Mariadason J, Corner G, Augenlicht L . Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 2000; 60(16):4561-72. View